Lipoxin A4 - Moligand™, ≥95%, 100µg/ml in ethanol , Agonist of FPR2/ALX;Agonist of FPR3;Agonist of GPR32, CAS No.89663-86-5, Agonist of FPR2/ALX;Agonist of FPR3;Agonist of GPR32

CAS: 89663-86-5 Cat. No.: L345922 Formule: C20H32O5 Poids moléculaire: 352.47 Numéro CE: 200-578-6
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥95% 100µg/ml in ethanol
Synonyms
(7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoate|7,9,11,13-Eicosatetraenoic acid, 5,6,15-trihydroxy-, (5S,6R,7E,9E,11Z,13E,15S)-|(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyeicosa-7,9,11,13-tetraenoic acid|(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid|5S,6S-Lipoxin A4|5(S),6(R),15(S)-trihydroxyeicosa-7E,9E,11Z,13E-tetraenoic acid|LXA4|5,6,15-triHETE|7,9,11,13-Eicosatetraenoicacid, 5,6,15-trihydroxy-, (5S,6R,7E,9E,11Z,13E,15S)-|5S,6R,15S-Trihydroxy-7E,9E,11Z,13E-eicosatetraenoate|5S,6R-LipoxinA4|LXA4-[19,19,20,20,20-d5]|5S,6R,15S-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid|lipoxin A4|(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxy-7,9,11,13-eicosatetraenoic acid|(7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoic acid|(5S,6R,15S)-trihydroxy-7,9,13-trans-11-cis-eicosatetraenoic acid|5S,6R,15S-trihydroxy-7E,9E,11Z,13E-Eicosatetraenoic acid|Lipoxin A
Storage
Argon charged,Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Taille
Allemagne (EU)
USA*
Prix
Qté
25μg
L345922-25μg
Sur commande · 8–12 semaines
728,81€
50μg
L345922-50μg
Sur commande · 8–12 semaines
1 353,59€
Enter a quantity for the sizes you want to add.

Vue d’ensemble

Lipoxin A4 (LXA4), an endogenous lipoxygenase-derived eicosanoid mediator, has potent dual pro-resolving and anti-inflammatory properties. Lipoxin A4 inhibits proliferation and inflammatory cytokine/chemokine production of human epidermal keratinocytes (NHEKs) associated with the ERK1/2 and NF-kB pathways. Lipoxin A4 inhibits serum amyloid A (SAA)-mediated IL-8 release with an IC50 value of 25.74 nM.

Spécifications

Synonymes
(7E,9E,11Z,13E)-(5S,6R,15S)-5,6,15-Trihydroxyicosa-7,9,11,13-tetraenoate | 7,9,11,13-Eicosatetraenoic acid, 5,6,15-trihydroxy-, (5S,6R,7E,9E,11Z,13E,15S)- | (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyeicosa-7,9,11,13-tetraenoic acid | (5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid | 5S,6S-Lipoxin A4 | 5(S),6(R) Afficher plus
Spécifications et pureté
Moligand™, ≥95%, 100µg/ml in ethanol
Mécanismes biochimiques et physiologiques
Lipoprotein A4 (LXA4) is synthesized from arachidonic acid and is an endogenous lipoxygenase derived arachidonic acid mediator. It is an effective activator of human protein kinase C. It inhibits the cytotoxicity of natural killer cells. LXA4 regulates the immune system and inflammation. In the brain, it regulates neuronal signal transduction and slow wave sleep. LXA4 binds to cannabinoid receptors. LXA4 plays a crucial role in the maintenance of the endometrium and reproductive function. The consumption of LXA4 contributes to the pathophysiology of cystic fibrosis (CF).
Conditions de stockage de stockage
Argon charged,Store at -80°C
Expédié en
Dry ice packs + Cold packs
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Grade
Moligand™
Type d'action
AGONIST
Mécanisme d'action
Agonist of FPR2/ALX;Agonist of FPR3;Agonist of GPR32
Note
Store as supplied at -80° C for up to 1 year.
Pureté
≥95%
Propriétés du produit
pKa
pKa: 4.67
Noms et identifiants
SMILES
CCCCCC(C=CC=CC=CC=CC(C(CCCC(=O)O)O)O)O
IUPAC Name
(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid
InChIKey
IXAQOQZEOGMIQS-SSQFXEBMSA-N
InChI
1S/C20H32O5/c1-2-3-8-12-17(21)13-9-6-4-5-7-10-14-18(22)19(23)15-11-16-20(24)25/h4-7,9-10,13-14,17-19,21-23H,2-3,8,11-12,15-16H2,1H3,(H,24,25)/b6-4-,7-5+,13-9+,14-10+/t17-,18+,19-/m0/s1
Isomères SMILES
CCCCC[C@@H](/C=C/C=C\C=C\C=C\[C@H]([C@H](CCCC(=O)O)O)O)O
WGK Allemagne
2
Poids moléculaire
352.47
Reaxys
34893640
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=34893640&ln=

Données avancées

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassLipids and lipid-like molecules
ClasseFatty Acyls
SubclassEicosanoids
Intermediate Tree Nodes Hydroxyeicosatetraenoic acids
Direct ParentLipoxins
Alternative Parents Long-chain fatty acids  Hydroxy fatty acids  Unsaturated fatty acids  Secondary alcohols  Polyols  Monocarboxylic acids and derivatives  Carboxylic acids  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAliphatic acyclic compounds
Substituents Lipoxin - Long-chain fatty acid - Hydroxy fatty acid - Fatty acid - Unsaturated fatty acid - Secondary alcohol - Carboxylic acid derivative - Carboxylic acid - Monocarboxylic acid or derivatives - Polyol - Organic oxide - Organic oxygen compound - Hydrocarbon derivative - Carbonyl group - Organooxygen compound - Alcohol - Aliphatic acyclic compound
DescriptionThis compound belongs to the class of organic compounds known as lipoxins. These are eicosanoids with a trihydroxyicosatetraenoic acid skeleton (a c20-fatty acid, with the chain bearing three hydroxyl groups and four double bonds). Lipoxins have four double bonds, which are all conjugated. In some cases a hydroxyl group is substituted by a C=O group.
External Descriptors Lipoxins
Structure 3D
Modèle de structure chimique interactif





Cibles associées (humaines)
GPR32 Tchem Probable G-protein coupled receptor 32 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FPR2 Tchem N-formyl peptide receptor 2 (7 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FPR3 Tchem N-formyl peptide receptor 3 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FPR2 Tchem Lipoxin A4 receptor (3472 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFKB2 Tchem Nuclear factor NF-kappa-B complex (2307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cibles associées (non humaines)
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mécanismes d'action
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate TypeDateArticle
I2404555I2404555Certificate of AnalysisAug 29, 2024 L345922
Propriétés chimiques et physiques
SolubilitéSoluble in ethanol, DMSO (≥50 mg/ml), DMF (≥50 mg/ml), and PBS (pH 7.2) (≥1 mg/ml).
Indice de réfractionn20D1.54
Point d'ébullition (°C)78° C
Poids moléculaire352.5
XLogP33.100
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count5
Rotatable Bond Count14
Exact Mass352.225 Da
Monoisotopic Mass352.225 Da
Topological Polar Surface Area98.000 Ų
Heavy Atom Count25
Formal Charge0
Complexity451.000
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count4
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds4
Covalently-Bonded Unit Count1
Sécurité et dangers (GHS)
Signal
Danger
Mentions de danger

H225:Highly Flammable liquid and vapor

H350:May cause cancer

Conseils de prudence

P210:Keep away from heat, hot surface, sparks, open flames and other ignition sources. - No smoking.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P337+P313:IF eye irritation persists: Get medical advice/attention.

P403+P235:Store in a well-ventilated place. Keep cool.

WGK Allemagne
2
Reaxys
34893640
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=34893640&ln=
RIDADR
UN1170-class3-PG2-Ethanol,solution
Citations of This Product
Calculateurs de solution
Avis

Avis des clients

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.